Sansure Biotech Inc. (SHA:688289)
China
· Delayed Price · Currency is CNY 19.92
-0.15 (-0.75%)
May 14, 2025, 2:44 PM CST
Sansure Biotech Revenue
Sansure Biotech had revenue of 475.49M CNY in the quarter ending March 31, 2025, with 21.62% growth. This brings the company's revenue in the last twelve months to 1.58B, up 31.44% year-over-year. In the year 2024, Sansure Biotech had annual revenue of 1.50B with 48.60% growth.
Revenue (ttm)
1.58B
Revenue Growth
+31.44%
P/S Ratio
7.24
Revenue / Employee
788.20K
Employees
2,006
Market Cap
11.44B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |